Frazier Financial Advisors »

Aurinia Pharmaceuticals shares owned by Frazier Financial Advisors

Quarter-by-quarter ownership of Aurinia Pharmaceuticals (AUPH) shares owned by Frazier Financial Advisors from 13F filings

Historical chart of Frazier Financial Advisors investment in Aurinia Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Aurinia Pharmaceuticals held by Frazier Financial Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aurinia Pharmaceuticals by Frazier Financial Advisors

Quarter filed Position value Share count Share price at filing
2023-12-31 $4.5k 500 8.99

More positions owned by Frazier Financial Advisors

Vanguard Specialized Funds Div App Etf (VIG)
Vanguard Index Fds Total Stk Mkt (VTI)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Wisdomtree Tr Currncy Int Eq (DDWM)
Wisdomtree Tr Us Midcap Divid (DON)
Wisdomtree Tr Us Smallcap Divd (DES)
Abbott Laboratories (ABT)
Vanguard Index Fds Small Cp Etf (VB)
Abbvie (ABBV)
Accenture Plc Ireland Shs Class A (ACN)
Apple (AAPL)
Goldman Sachs Etf Tr Aces Ultra Shr (GSST)
Bath &#38 Body Works In (BBWI)
Goldman Sachs Etf Tr Acces Treasury (GBIL)
Microsoft Corporation (MSFT)

View all positions for Frazier Financial Advisors

Top funds holding Aurinia Pharmaceuticals

NEA Management Company
Goldman Sachs Group
Citadel Advisors
Vanguard Group
Citigroup
Balyasny Asset Management
Caption Management
Jane Street
Tang Capital Management
Charles Schwab Investment Management
Bank of New York Mellon
Stifel Financial
GSA Capital Partners
Nordea Investment Management Ab
Barclays

View all funds holding Aurinia Pharmaceuticals